Literature DB >> 21392793

Hydrogen-rich saline protects against renal ischemia/reperfusion injury in rats.

Fei Wang1, Guang Yu, Sui-Yi Liu, Jin-Bao Li, Jia-Feng Wang, Lu-Long Bo, Li-Ren Qian, Xue-Jun Sun, Xiao-Ming Deng.   

Abstract

BACKGROUND: Recently it has been demonstrated that hydrogen, as a novel antioxidant, can selectively reduce hydroxyl radicals (·OH) and peroxynitrite anion (ONOO-) in vitro and exert therapeutic antioxidant activity in many diseases. This study was designed to investigate the effect of hydrogen-rich saline on renal ischemia/reperfusion (I/R) injury in rats.
METHODS: A rat model of renal I/R injury was induced by 45-min occlusion of the bilateral renal pedicles and 24-h reperfusion. Physiologic saline, hydrogen-rich saline, or nitrogen-rich saline (8 mL/kg) were administered intraperitoneally at 5 min before reperfusion, respectively.
RESULTS: After I/R injury, serum blood urea nitrogen (BUN), creatinine (Cr), tissue malondialdehyde (MDA), 8-hydroxydeoxyguanosine (8-OhdG), TNF-α, IL-1β, IL-6 levels, and myeloperoxidase (MPO) activity were all increased significantly, while tissue superoxide dismutase (SOD) and catalase (CAT) activities were all decreased significantly. Hydrogen-rich saline reversed these changes and relieved morphological renal injury and I/R-induced apoptosis, while no significant changes were observed in the nitrogen-rich saline-treated group compared with physiologic saline-treated group.
CONCLUSIONS: Hydrogen-rich saline is able to attenuate the renal I/R injury, which is possibly by reduction of oxidative stress and inflammation.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21392793     DOI: 10.1016/j.jss.2010.11.005

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  35 in total

1.  Three hydrogen-rich solutions protect against intestinal injury in uncontrolled hemorrhagic shock.

Authors:  Zunmin Du; Jing Liu; Haipeng Jia; Wei Xu; Xiaomin Zhao
Journal:  Int J Clin Exp Med       Date:  2015-05-15

2.  Lung inflation with hydrogen during the cold ischemia phase decreases lung graft injury in rats.

Authors:  Rongfang Liu; Xianhai Fang; Chao Meng; Jingchun Xing; Jinfeng Liu; Wanchao Yang; Wenzhi Li; Huacheng Zhou
Journal:  Exp Biol Med (Maywood)       Date:  2015-02-07

3.  Hydrogen-Rich Saline Ameliorates Hepatic Ischemia-Reperfusion Injury Through Regulation of Endoplasmic Reticulum Stress and Apoptosis.

Authors:  Zhiyuan Lu; Yanzhu Lin; Bo Peng; Zhen Bao; Kexin Niu; Jin Gong
Journal:  Dig Dis Sci       Date:  2017-10-30       Impact factor: 3.199

4.  Hydrogen inhalation protects hypoxic-ischemic brain damage by attenuating inflammation and apoptosis in neonatal rats.

Authors:  Guojiao Wu; Zhiheng Chen; Peipei Wang; Mingyi Zhao; Masayuki Fujino; Chen Zhang; Wenjuan Zhou; Shin-Ichi Hirano; Xiao-Kang Li; Lingling Zhao
Journal:  Exp Biol Med (Maywood)       Date:  2019-06-12

5.  Chronic hydrogen-rich saline treatment reduces oxidative stress and attenuates left ventricular hypertrophy in spontaneous hypertensive rats.

Authors:  Yong-Sheng Yu; Hao Zheng
Journal:  Mol Cell Biochem       Date:  2012-02-18       Impact factor: 3.396

6.  Tanshinone IIA pretreatment attenuates ischemia/reperfusion-induced renal injury.

Authors:  Yan-Mei Xu; Guo-Hua Ding; Jie Huang; Yan Xiong
Journal:  Exp Ther Med       Date:  2016-09-06       Impact factor: 2.447

7.  Hydrogen-rich saline attenuates steroid-associated femoral head necrosis through inhibition of oxidative stress in a rabbit model.

Authors:  Sheng-Li Huang; Jian Jiao; Hong-Wei Yan
Journal:  Exp Ther Med       Date:  2015-11-19       Impact factor: 2.447

8.  Hydrogen-rich saline protects immunocytes from radiation-induced apoptosis.

Authors:  Yanyong Yang; Bailong Li; Cong Liu; Yunhai Chuai; Jixiao Lei; Fu Gao; Jianguo Cui; Ding Sun; Ying Cheng; Chuanfeng Zhou; Jianming Cai
Journal:  Med Sci Monit       Date:  2012-04

9.  Hydrogen therapy may be an effective and specific novel treatment for acute graft-versus-host disease (GVHD).

Authors:  Liren Qian; Jianliang Shen
Journal:  J Cell Mol Med       Date:  2013-06-07       Impact factor: 5.310

10.  The evolution of molecular hydrogen: a noteworthy potential therapy with clinical significance.

Authors:  Brandon J Dixon; Jiping Tang; John H Zhang
Journal:  Med Gas Res       Date:  2013-05-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.